Jerry S. Wolinsky, M.D., professor emeritus of neurology, recently was recognized with two prestigious distinctions for his innovation and dedication to helping those with multiple sclerosis (MS).
A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School.
A physician-scientist who specializes in brain injury has been recruited to the Department of Neurology and recognized as a Rising STAR by the University of Texas System.
The fifth annual Stomp Out Stroke Festival to raise stroke awareness will be hosted by the The University of Texas Health Science Center at Houston (UTHealth) Stroke Team from 9 a.m. to 3:30 p.m. Saturday, May 6 at Discovery Green, Jones Lawn, 1500 McKinney St. The free, fun event will provide lifesaving information about stroke prevention and treatment and will include free health screenings. Register today at http://www.strokefestival.org/.
As the American Heart Association’s International Stroke Conference 2017 wrapped up its first ever conference in Houston, McGovern faculty took home more than just a host of memories.
Positive results of an investigational medication study for primary progressive multiple sclerosis were published online last month in the New England Journal of Medicine in a paper led by senior author Jerry Wolinsky, M.D., Professor Emeritus of neurology at McGovern Medical School.
The detection of prions in the blood of patients with variant Creutzfeldt-Jakob disease could lead to a noninvasive diagnosis prior to symptoms and a way to identify prion contamination of the donated blood supply, according to researchers at McGovern Medical School.
For nearly three decades, behind a big, bright smile and cheerful demeanor, Brandy Chandler struggled through daily activities with an illness diagnosed in her adolescence as Marfan syndrome.
The Department of Neurology at McGovern Medical School at The University of Texas Health Science Center at Houston announces the 28th annual William S. Fields Lecture.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to McGovern Medical School researchers.